ALERT

S&P Global Market Intelligence to Collaborate with DTCC on T+1 Offering

Retrieved on: 
Wednesday, March 13, 2024
ALERT, S&P Global, Organization, Database, Improper integral, Communication, KYC, DTCC, T+1, Christianity in Singapore, API, SPGI, SSI, Regulation, Security (finance)

NEW YORK, March 13, 2024 /PRNewswire/ -- S&P Global Market Intelligence, a division of S&P Global (NYSE: SPGI) today announced plans to collaborate with DTCC, the premier post-trade market infrastructure for the global financial services industry, to deliver a joint solution to support clients impacted by upcoming U.S. T+1 settlement requirements. The organizations plan to link S&P Global Market Intelligence's Onboarding Accelerator platform with DTCC's ALERT to increase transparency, efficiency and straight-through processing in the institutional trading industry.

Key Points: 
  • NEW YORK, March 13, 2024 /PRNewswire/ -- S&P Global Market Intelligence, a division of S&P Global (NYSE: SPGI) today announced plans to collaborate with DTCC, the premier post-trade market infrastructure for the global financial services industry, to deliver a joint solution to support clients impacted by upcoming U.S. T+1 settlement requirements.
  • The organizations plan to link S&P Global Market Intelligence's Onboarding Accelerator platform with DTCC's ALERT to increase transparency, efficiency and straight-through processing in the institutional trading industry.
  • By linking the services, Onboarding Accelerator users will be able to query the status of critical standing settlement instructions (SSI) reference data for a particular account and market directly within the S&P Global Market Intelligence platform.
  • It will streamline a manual, antiquated process, maximizing efficiency and minimizing trade settlement failures," said Brittany Garland, Head of Regulatory & Compliance for Enterprise Solutions, S&P Global Market Intelligence.

InventHelp Inventor Develops New Automotive Safety System (LAX-785)

Retrieved on: 
Friday, October 6, 2023
ALERT, Multimedia, CODE, Accident, Confusion, Suite, Sale

I thought there should be an effective alert system for drivers," said an inventor, from Las Vegas, Nev. "So I invented the CODE 3 ALERT SYSTEM.

Key Points: 
  • I thought there should be an effective alert system for drivers," said an inventor, from Las Vegas, Nev. "So I invented the CODE 3 ALERT SYSTEM.
  • The invention provides an effective way to alert motorists of approaching emergency vehicles.
  • The original design was submitted to the Los Angeles sales office of InventHelp.
  • 22-LAX-785, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext.

Parion Sciences Announces Publication of Phase 2 CLEAN-PCD Study in The Lancet Respiratory Medicine

Retrieved on: 
Friday, September 8, 2023
Abstract (summary), PCD, The Lancet, ALERT, Quality of life, Research, Patient, Drug development, Primary ciliary dyskinesia, Disease, Pharmaceutical industry, Parium, MD

DURHAM, N.C., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Parion Sciences Inc. today announced publication in The Lancet Respiratory Medicine of positive results of the Phase 2 study of idrevloride in hypertonic saline in people with primary ciliary dyskinesia (PCD).

Key Points: 
  • DURHAM, N.C., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Parion Sciences Inc. today announced publication in The Lancet Respiratory Medicine of positive results of the Phase 2 study of idrevloride in hypertonic saline in people with primary ciliary dyskinesia (PCD).
  • For the first time, it demonstrates a safe pharmaceutical intervention improving lung function – a prerequisite for holding the progression of PCD-associated lung disease.
  • The CLEAN-PCD study was a multinational, randomized, double-blind, placebo-controlled crossover trial in adults and adolescents with primary ciliary dyskinesia aged 12 years or older.
  • In addition to publication in The Lancet Respiratory Medicine, Thomas W. Ferkol, Jr MD will present the CLEAN-PCD study results at the European Respiratory Society International Congress 2023 during the Abstracts Leading to Evolution in Respiratory Medicine Trials (ALERT) session on the morning of 10 September.

Bristol Myers Squibb’s Investigational LPA1 Antagonist Reduces Rate of Lung Function Decline in Progressive Pulmonary Fibrosis Cohort of Phase 2 Study

Retrieved on: 
Saturday, September 9, 2023
Biotechnology, Pharmaceutical, Health, Clinical Trials, LPAR1, Bristol Myers Squibb, Abstract (summary), European Respiratory Society, LPA1, Consultant, UIP, Survival, Policy, ALERT, PPF, BMY, ERS, Pulmonary fibrosis, Restrictive lung disease, Patient, Respiratory Medicine, IPF, International Congress on Tuberculosis, NYSE, Idiopathic pulmonary fibrosis, Pharmaceutical industry

Bristol Myers Squibb (NYSE: BMY) today announced results from a Phase 2 study evaluating BMS-986278, a potential first-in-class, oral, lysophosphatidic acid receptor 1 (LPA1) antagonist in patients with progressive pulmonary fibrosis (PPF).

Key Points: 
  • Bristol Myers Squibb (NYSE: BMY) today announced results from a Phase 2 study evaluating BMS-986278, a potential first-in-class, oral, lysophosphatidic acid receptor 1 (LPA1) antagonist in patients with progressive pulmonary fibrosis (PPF).
  • The study showed that twice-daily administration of 60 mg of BMS-986278 over 26 weeks reduced the rate of decline in percent predicted forced vital capacity (ppFVC) by 69% compared to placebo (overall, 38% of patients in the study received background antifibrotic therapy).
  • Stable background use of antifibrotics in the IPF cohort and/or select immunosuppressives in the PPF cohort were allowed.
  • The primary endpoint of the study was rate of change in ppFVC from baseline to Week 26 in the IPF cohort.

Generational Equity Advises HydroLynx Systems in its Sale to ISG Devices

Retrieved on: 
Wednesday, June 7, 2023
Other Manufacturing, Technology, Finance, Other Technology, Professional Services, Manufacturing, Machinery, Machine Tools, Metalworking & Metallurgy, Hardware, Electronic Design Automation, SCADA, ALERT, Equity, Sale, Acquisition, Acoustics, Weather, Telemetry, Sales

Generational Equity , a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client, HydroLynx Systems, Inc. to ISG Devices.

Key Points: 
  • Generational Equity , a leading mergers and acquisitions advisor for privately held businesses, is pleased to announce the sale of its client, HydroLynx Systems, Inc. to ISG Devices.
  • HydroLynx Systems , located in Sacramento, California, manufactures Real Time Data Telemetry Systems.
  • Located in Nashville, Tennessee, ISG Devices was founded by two executives with extensive experience in businesses that specialized in detection and measurement devices.
  • The acquisition of TF Acoustics was completed in Q4 2021 which added the ACUPRO and ACUPAV acoustic measurement systems to the product portfolio.

InventHelp Inventor Develops Improved Safety Fall Arrest System (DNV-480)

Retrieved on: 
Friday, June 9, 2023
Communication, Fatality, Occupational Safety and Health Act 1994, ALERT, Documentation, Emergency service, Occupational Safety and Health Professional Day, Multimedia, Falls, Safety, Sale, Risk management

I felt that there could be an improved 5-Point Safety Harness / Fall Arrest System that could send an alert to a Co-Worker or Emergency Service in the event of a fall," said an inventor, from Federal Heights, Colo., "With the invention of the ALERT LANYARD I could provide communication, notification and documentation ensuring a more speedy response and recovery time in the event of a fall or Lanyard Deployment."

Key Points: 
  • I felt that there could be an improved 5-Point Safety Harness / Fall Arrest System that could send an alert to a Co-Worker or Emergency Service in the event of a fall," said an inventor, from Federal Heights, Colo., "With the invention of the ALERT LANYARD I could provide communication, notification and documentation ensuring a more speedy response and recovery time in the event of a fall or Lanyard Deployment."
  • The invention provides an emergency alert and summoning system for fall arresters used with 5-point body safety harnesses.
  • In doing so, it can be used to detect a fall and call for help.
  • As a result, it enhances safety and it minimizes delays.

InventHelp Inventor Develops Padlock with Electronic Tamperproof Capabilities (RSM-118)

Retrieved on: 
Wednesday, January 25, 2023
Sale, Safety, ALERT, Theft, Multimedia, Online shopping

PITTSBURGH, Jan. 25, 2023 /PRNewswire/ -- "I wanted to create an improved padlock to prevent tampering and theft," said an inventor, from Corona, Calif., "so I invented the ALERT LOCK.

Key Points: 
  • PITTSBURGH, Jan. 25, 2023 /PRNewswire/ -- "I wanted to create an improved padlock to prevent tampering and theft," said an inventor, from Corona, Calif., "so I invented the ALERT LOCK.
  • My design can be used with storage units, sheds, garages, campers, bicycles, and other lockable devices."
  • The invention offers an improved padlock with electronic tamperproof capabilities.
  • The original design was submitted to the Riverside sales office of InventHelp.

Revolutionary Crypto Trading Platform $ALERT Launches with Real-Time Notifications and Mobile Compatibility

Retrieved on: 
Monday, February 6, 2023
Tier 2, Marketing, Tier 3, Growth, Treasury, ALERT, Tier 4, Cryptocurrency, Distribution (marketing)

This provides a convenient way for users to stay informed, whether they are on their desktop or mobile device.

Key Points: 
  • This provides a convenient way for users to stay informed, whether they are on their desktop or mobile device.
  • The platform provides real-time notifications, instant alerts, and a ranking system, all designed to help users make more informed investment decisions.
  • In addition to that, the goal with $ALERT is to provide a unique trading platform that offers real-time information and convenience to users.
  • The platform is mobile compatible and allows for easy trigger setting through its mobile application.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Centessa Pharmaceuticals plc

Retrieved on: 
Tuesday, September 6, 2022
American depositary receipt, Observation, NASDAQ, LLP, AST, ALT, AE, ADPKD, GLOBE, Company, Secondary research, News, ALERT, Pomerantz, BID, CNTA, Patient, Private investigator

NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Centessa Pharmaceutical plc (CNTA or the Company) (NASDAQ:CNTA).

Key Points: 
  • NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Centessa Pharmaceutical plc (CNTA or the Company) (NASDAQ:CNTA).
  • The investigation concerns whether Centessa and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • On or around May 27, 2021, Centessa conducted its initial public offering (IPO), selling 16.5 American Depositary Shares (ADSs) priced at $20.00 per share.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Centessa Pharmaceuticals plc Investors to Inquire About Securities Class Action Investigation – CNTA

Retrieved on: 
Saturday, September 3, 2022
Titan, TO, ADS, American depositary receipt, Observation, NASDAQ, WHY, AST, ALT, LinkedIn, AE, ADPKD, GLOBE, Secondary research, Company, News, ALERT, Twitter, Facebook, Advertising, BID, I-Space (Chinese company), CNTA, Patient, Security (finance)

The Rosen Law Firm is preparing a class action seeking recovery of investor losses.

Key Points: 
  • The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
  • WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=8067 or call Phillip Kim, Esq.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.